Skip to main content

Peer Review reports

From: Efficacy and safety analysis of angiotensin receptor neprilysin inhibition(ARNI)in patients with heart failure: a real-world retrospective study

Original Submission
21 Nov 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
6 Mar 2023 Reviewed Reviewer Report - Hongdong Chen
8 May 2023 Reviewed Reviewer Report
18 May 2023 Author responded Author comments - Houxiang Hu
Resubmission - Version 4
18 May 2023 Submitted Manuscript version 4
19 May 2023 Author responded Author comments - Houxiang Hu
Resubmission - Version 5
19 May 2023 Submitted Manuscript version 5
22 May 2023 Author responded Author comments - Houxiang Hu
Resubmission - Version 6
22 May 2023 Submitted Manuscript version 6
25 May 2023 Reviewed Reviewer Report
8 Jun 2023 Reviewed Reviewer Report - Hongdong Chen
20 Jun 2023 Author responded Author comments - Houxiang Hu
Resubmission - Version 7
20 Jun 2023 Submitted Manuscript version 7
Publishing
29 Jun 2023 Editorially accepted
10 Jul 2023 Article published 10.1186/s12872-023-03374-w

You can find further information about peer review here.

Back to article page